Search research articles
Contact Us
Filters
Showing results (311-320 of 1,211) with videos related to
Page
of 122
Sort By:
American Heart Journal
|
August 1, 2006
Rationale and design: the VALsartan In Diastolic Dysfunction (VALIDD) Trial: evolving the management of diastolic dysfunction in hypertension
Rajesh Janardhanan, William L Daley, Tasneem Z Naqvi, et al.
Clinical Chemistry
|
November 22, 2017
Weight History and Subclinical Myocardial Damage
Chiadi E Ndumele, Laura Cobb, Mariana Lazo, et al.
European Journal of Heart Failure
|
June 11, 2021
Influence of study discontinuation during the run-in period on the estimated efficacy of sacubitril/valsartan in the PARAGON-HF trial
Kota Suzuki, Brian Claggett, Masatoshi Minamisawa, et al.
The American Journal of Cardiology
|
March 1, 2008
Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study)
Nagesh S Anavekar, Hicham Skali, Mikhail Bourgoun, et al.
Heart Rhythm
|
February 8, 2014
Cardiac resynchronization therapy is associated with reductions in left atrial volume and inappropriate implantable cardioverter-defibrillator therapy in MADIT-CRT
Tyler Slyngstad, Anne-Christine Huth Ruwald, Valentina Kutyifa, et al.
Journal of the American Heart Association
|
August 10, 2022
Risk of Dementia Associated With Atrial Cardiopathy: The ARIC Study
Michelle C Johansen, Wendy Wang, Michael Zhang, et al.
Journal of the American College of Cardiology
|
February 22, 2023
Variation in Renal Function Following Transition to Sacubitril/Valsartan in Patients With Heart Failure
Safia Chatur, Brian L Claggett, Finnian R McCausland, et al.
Circulation
|
April 1, 2026
Cardiovascular-Kidney-Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study
Mats C Højbjerg Lassen, John W Ostrominski, Brian L Claggett, et al.
Chest
|
May 13, 2022
Association of Right Ventricular Afterload With Atrial Fibrillation Risk in Older Adults: The Atherosclerosis Risk in Communities Study
Romil R Parikh, Faye L Norby, Wendy Wang, et al.
The American Journal of Cardiology
|
September 22, 2010
Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunction
Amil M Shah, Marc A Pfeffer, L Howard Hartley, et al.
Page
of 122
Search research articles
Search
Showing results (311-320 of 1,211) with videos related to
Sort By:
Page
of 122
American Heart Journal
|
August 1, 2006
Rationale and design: the VALsartan In Diastolic Dysfunction (VALIDD) Trial: evolving the management of diastolic dysfunction in hypertension
Rajesh Janardhanan, William L Daley, Tasneem Z Naqvi, et al.
Clinical Chemistry
|
November 22, 2017
Weight History and Subclinical Myocardial Damage
Chiadi E Ndumele, Laura Cobb, Mariana Lazo, et al.
European Journal of Heart Failure
|
June 11, 2021
Influence of study discontinuation during the run-in period on the estimated efficacy of sacubitril/valsartan in the PARAGON-HF trial
Kota Suzuki, Brian Claggett, Masatoshi Minamisawa, et al.
The American Journal of Cardiology
|
March 1, 2008
Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study)
Nagesh S Anavekar, Hicham Skali, Mikhail Bourgoun, et al.
Heart Rhythm
|
February 8, 2014
Cardiac resynchronization therapy is associated with reductions in left atrial volume and inappropriate implantable cardioverter-defibrillator therapy in MADIT-CRT
Tyler Slyngstad, Anne-Christine Huth Ruwald, Valentina Kutyifa, et al.
Journal of the American Heart Association
|
August 10, 2022
Risk of Dementia Associated With Atrial Cardiopathy: The ARIC Study
Michelle C Johansen, Wendy Wang, Michael Zhang, et al.
Journal of the American College of Cardiology
|
February 22, 2023
Variation in Renal Function Following Transition to Sacubitril/Valsartan in Patients With Heart Failure
Safia Chatur, Brian L Claggett, Finnian R McCausland, et al.
Circulation
|
April 1, 2026
Cardiovascular-Kidney-Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study
Mats C Højbjerg Lassen, John W Ostrominski, Brian L Claggett, et al.
Chest
|
May 13, 2022
Association of Right Ventricular Afterload With Atrial Fibrillation Risk in Older Adults: The Atherosclerosis Risk in Communities Study
Romil R Parikh, Faye L Norby, Wendy Wang, et al.
The American Journal of Cardiology
|
September 22, 2010
Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunction
Amil M Shah, Marc A Pfeffer, L Howard Hartley, et al.
Page
of 122